Faeth Therapeutics, Inc. (FTH)
NASDAQ: FTH · Real-Time Price · USD
40.05
+1.05 (2.69%)
At close: Sep 4, 2026, 4:00 PM EDT
40.50
+0.45 (1.12%)
After-hours: Sep 4, 2026, 7:30 PM EDT
Faeth Therapeutics Employees
Faeth Therapeutics had 29 employees as of December 31, 2025. The number of employees increased by 14 or 93.33% compared to the previous year.
Employees
29
Change (1Y)
14
Growth (1Y)
93.33%
Revenue / Employee
n/a
Profits / Employee
-$6,742,345
Market Cap
1.03B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 29 | 14 | 93.33% | 29 | 0 |
| Dec 31, 2024 | 15 | -13 | -46.43% | 14 | 1 |
| Dec 31, 2023 | 28 | 0 | - | 27 | 1 |
| Dec 31, 2022 | 28 | -28 | -50.00% | 28 | 0 |
| Dec 31, 2021 | 56 | 24 | 75.00% | 56 | 0 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Geron | 258 |
| Solid Biosciences | 121 |
| Adlai Nortye Group | 109 |
| Lexicon Pharmaceuticals | 81 |
| Inventiva | 77 |
| SpyGlass Pharma | 76 |
| Candel Therapeutics | 55 |
| Avalo Therapeutics | 33 |
FTH News
- 4 days ago - Faeth Therapeutics to Participate in Upcoming September Investor Conferences - Business Wire
- 8 days ago - Faeth Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
- 15 days ago - Faeth Therapeutics initiated with a Buy at Needham - TheFly
- 19 days ago - Faeth Therapeutics granted Fast Track desingation for PIKTOR plus Paclitaxel - TheFly
- 19 days ago - Faeth Therapeutics Announces FDA Grant of Fast Track Designation for PIKTOR Plus Paclitaxel in Biomarker-Selected Advanced Endometrial Cancer - Business Wire
- 20 days ago - Faeth Therapeutics appoints Tiwari, Biegler as Senior Vice Presidents - TheFly
- 22 days ago - Faeth Therapeutics Strengthens Executive Team with Senior Leadership Appointments - Business Wire
- 4 weeks ago - Faeth Therapeutics to Present PK/PD Modeling That Informed PIKTOR Dose Selection in Ongoing FTH-PIK-201 Trial at Upcoming Scientific Conference - Business Wire